Chart calendar Enliven Therapeutics, Inc.

01a31a492e6af44be82.UtIAS8J9JxiCaI-C3TbSn7UdN4ZRNi2ppqjXmlolUOg.C4EwO4kXFCH6L_nSmmG4-4B2c9E1UX3N3uqDry1KIb8YnjN4hB8fXsw5zg~b06e99ee2bc865b2bf2b7f58cf37acd4

Upcoming events on Enliven Therapeutics, Inc.

24/06/2025 20:00 Annual General Meeting
06/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)
11/03/2026 Q4 2025 Earnings Release (Projected)
19/05/2026 Q1 2026 Earnings Release (Projected)

Past events on Enliven Therapeutics, Inc.

13/06/2025 18:30 European Hematology Association Congress
13/06/2025 16:00 European Hematology Association Congress - Abstract No: S165
10/06/2025 21:00 Goldman Sachs Global Healthcare Conference
04/06/2025 21:20 Jefferies Healthcare Conference
27/05/2025 18:00 TD Cowen Oncology Innovation Summit
14/05/2025 21:05 Q1 2025 Earnings Release
29/04/2025 20:00 American Association for Cancer Research Meeting - Abstract 5515
29/04/2025 15:00 American Association for Cancer Research Meeting - Abstract 4361
29/04/2025 15:00 American Association for Cancer Research Meeting - Abstract 4712
29/04/2025 15:00 American Association for Cancer Research Meeting - Abstract LB294
29/04/2025 15:00 American Association for Cancer Research Meeting - Abstract LB295
13/03/2025 20:05 Q4 2024 Earnings Release
04/03/2025 15:30 TD Cowen Healthcare Conference
19/11/2024 09:30 Jefferies London Healthcare Conference
13/11/2024 21:05 Q3 2024 Earnings Release
27/09/2024 European Society of Hematology International Chronic Myeloid Leukemia Foundation John Goldman Confer
13/08/2024 21:05 Q2 2024 Earnings Release
18/06/2024 17:00 Annual General Meeting
10/06/2024 20:20 Goldman Sachs Global Healthcare Conference - Fireside Chat
05/06/2024 13:30 Jefferies Global Healthcare Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,01


0,01


0,01

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-83,5
-85,3
2.08%
-104
-106
1.34%

-136


-198


-265

EBIT
Million USD
Released
Forecast
Spread
-38,8
-40,0
3.02%
-83,5
-85,9
2.73%
-105
-106
1.49%

-132


-157


-199

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-37,7
-39,9
5.61%
-71,6
-74,2
3.53%
-89,0
-91,0
2.16%

-119


-146


-189

Net income
Million USD
Released
Forecast
Spread
-37,7
-39,9
5.61%
-71,6
-74,2
3.53%
-89,0
-91,0
2.15%

-119


-146


-189

EPS
USD
Released
Forecast
Spread
-3,56
-3,80
6.32%
-2,01
-2,16
7.05%
-1,89
-1,95
3.01%

-2,29


-2,73


-3,31

Announcement Date21/03/2314/03/2413/03/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,01


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-24,2
-21,7
-11.57%
-22,7
-25,1
9.34%
-26,0
-25,5
-1.82%
-24,6
-28,3
12.93%
-27,1
-26,4
-2.5%
-26,9
-28,5
5.48%
-31,7
-28,8
-9.98%

-32,4


-33,5


-34,8


-36,7


-37,7


-38,8


-39,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,8
-18,5
-12.25%
-19,4
-22,4
13.52%
-22,7
-23,9
4.9%
-20,0
-26,1
23.53%
-23,2
-22,9
-0.95%
-23,2
-25,2
7.99%
-28,5
-24,9
-14.76%

-29,2


-29,9


-31,2


-34,0


-35,1


-36,3


-37,5

Net income
Million USD
Released
Forecast
Spread
-20,8
-18,5
-12.25%
-19,4
-22,4
13.52%
-22,7
-23,9
4.9%
-20,0
-26,1
23.53%
-23,2
-22,9
-0.95%
-23,2
-25,2
7.99%
-28,5
-24,9
-14.76%

-29,2


-29,9


-31,2


-34,0


-35,1


-36,3


-37,5

EPS
USD
Released
Forecast
Spread
-0,51
-0,47
-7.94%
-0,47
-0,54
12.96%
-0,54
-0,57
4.71%
-0,41
-0,56
27.05%
-0,48
-0,50
3.45%
-0,46
-0,52
11.11%
-0,57
-0,50
-13.03%

-0,56


-0,57


-0,60


-0,67


-0,69


-0,71


-0,73

Announcement Date09/11/2314/03/2414/05/2413/08/2413/11/2413/03/2514/05/25-------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. Calendar Enliven Therapeutics, Inc.